Corvus Pharmaceuticals (CRVS) vs Rigel Pharmaceuticals (RIGL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Rigel Pharmaceuticals (RIGL) has outperformed Corvus Pharmaceuticals (CRVS) over the past year, gaining 62.7% versus a gain of 51.5%. Over five years, CRVS leads with a +110.3% price change compared with +42.0% for RIGL. Rigel Pharmaceuticals is the larger company by market cap ($896.4 million vs $875.7 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CRVS | RIGL |
|---|---|---|
| Share price | $10.41 | $47.99 |
| Market cap | $875.70M | $896.45M |
| 1-day change | -1.42% | +4.08% |
| YTD return | +35.19% | +12.05% |
| 1-year return | +51.53% | +62.68% |
| 5-year return | +110.30% | +41.98% |
| P/E ratio (TTM) | — | 2.73 |
| Forward P/E | — | 9.72 |
| EPS (TTM) | $-0.61 | $17.61 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $26.95 | $52.24 |
| 52-week low | $6.39 | $24.95 |
| Distance from 52-week high | -61.37% | -8.14% |
| Average volume | 970.42K | 291.58K |
| Shares outstanding | 84.12M | 18.68M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- RIGL has outperformed CRVS by 11.1 percentage points over the past year.
CRVS vs RIGL FAQ
Which is bigger, Corvus Pharmaceuticals or Rigel Pharmaceuticals?
Rigel Pharmaceuticals (RIGL) is larger, with a market capitalization of $896.45M compared with $875.70M for Corvus Pharmaceuticals (CRVS).
Which stock has performed better over the past year, CRVS or RIGL?
RIGL returned +62.68% over the past 12 months, compared with +51.53% for CRVS (price return, excluding dividends). Past performance does not predict future results.
Are Corvus Pharmaceuticals and Rigel Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.